1. Home
  2. V vs PFE Comparison

V vs PFE Comparison

Compare V & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visa Inc.

V

Visa Inc.

SELL

Current Price

$419.17

Market Cap

794.0B

ML Signal

SELL

Logo Pfizer Inc.

PFE

Pfizer Inc.

SELL

Current Price

$28.47

Market Cap

161.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
V
PFE
Founded
1958
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
794.0B
161.2B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
V
PFE
Price
$419.17
$28.47
Analyst Decision
Buy
Hold
Analyst Count
40
28
Target Price
★ $449.06
$30.22
AVG Volume (30 Days)
6.3M
★ 23.3M
Earning Date
10-27-2026
11-03-2026
Dividend Yield
0.73%
★ 5.96%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.99
Revenue
$21,846,000,000.00
★ $62,579,000,000.00
Revenue This Year
$11.25
$0.88
Revenue Next Year
$10.91
N/A
P/E Ratio
$30.09
★ $29.17
Revenue Growth
N/A
★ N/A
52 Week Low
$293.89
$23.62
52 Week High
$442.23
$31.44

Technical Indicators

Market Signals
Indicator
V
PFE
Relative Strength Index (RSI) 57.27 41.84
Support Level $357.85 $26.68
Resistance Level $442.23 $28.94
Average True Range (ATR) 9.11 0.71
MACD -1.23 -0.23
Stochastic Oscillator 41.09 2.33

Price Performance

Historical Comparison
V
PFE

About V Visa Inc.

Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Share on Social Networks: